Cardano wins £10bn mandate from pharma giant

Consultant has wrested an advisory contract worth over £10 billion of GlaxoSmithKline assets from Aon Hewitt

Pharmaceuticals company GlaxoSmithKline has appointed Cardano as investment adviser to assets worth £10 billion owned by its final salary pension scheme.

Cardano, an Anglo-Dutch investment consultant, is taking over the contract from Aon Hewitt, which confirmed the loss, although it added that it had retained some actuarial work.

WSJ Logo
JPMorgan to Pay $330 Million Over 1MDB TransactionsExternal link

JPMorgan to Pay $330 Million Over 1MDB Transactions